Ki-67 antigen expression before and after eradication therapy in H.pylori infected patients

Brajša, Karmen; Dominis, Marija; Katičić, Mirjana; Radošević, Senka; Spaventi, Radan; Presečki, Vladimir; Kalenić, Smilja; Ferenčić, Željko

Pregled bibliografske jedinice broj: 147638

Ki-67 antigen expression before and after eradication therapy in H.pylori infected patients

Brajša, Karmen; Dominis, Marija; Katičić, Mirjana; Radošević, Senka; Spaventi, Radan; Presečki, Vladimir; Kalenić, Smilja; Ferenčić, Željko

Ki-67 antigen expression before and after eradication therapy in H.pylori infected patients // Digestion, 59 (1998), 3; 402-402 (podatak o recenziji nije dostupan, kongresno priopcenje, ostalo)

CROSBI ID: 147638 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Ki-67 antigen expression before and after eradication therapy in H.pylori infected patients

Autori
Brajša, Karmen ; Dominis, Marija ; Katičić, Mirjana ; Radošević, Senka ; Spaventi, Radan ; Presečki, Vladimir ; Kalenić, Smilja ; Ferenčić, Željko

Izvornik
Digestion (0012-2823) 59 (1998), 3; 402-402

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, kongresno priopcenje, ostalo

Ključne riječi
Ki-67; H. pylori

Sažetak
There is an increasing evidence that H. pylori infection plays a major role in aetiology of gastric cancer. The proliferate activity of cells has been shown to be increased in gastric cancer. Ki-67 monoclonal antibody is an useful proliferation marker in tissues, since it recognises a nuclear antigen associated with cell proliferation. We assessed gastric mucosal cell proliferation determined by Ki-67 immunostaining before and after standard triple therapy.

Izvorni jezik
Engleski

Znanstvena područja
Temeljne medicinske znanosti

POVEZANOST RADA

Ustanove:
Klinička bolnica "Merkur"

Profili:

Marija Dominis (autor)